peritoneal perfusion

peritoneal perfusion

Therapeutics A method of delivering fluids and drugs directly to tumors in the peritoneal cavity by direct instillation. See Peritoneal dialysis.
References in periodicals archive ?
Literature review shows that the overall response rate with a single agent combined intraperitoneal chemotherapy and continuous hyperthermic peritoneal perfusion are 13.
Overall survival of 17 and 92 months (70%) 5-year overall survival 63% disease-free survival and 51% progression-free survival after cytoreductive surgery and continuous hyperthermic peritoneal perfusion with Cisplatin Fluorouracil and Paclitaxel reported in literature.
Cytoreductive surgery associated with continuous hyperthermic peritoneal perfusion (cisplatin at 42[degrees]C, for 1 hr) was performed.
This was followed by peritoneal perfusion with cisplatin heated at 42[degrees]C for 1 hr.
After the correct diagnosis was formulated, the patient was treated with cytoreductive surgery associated with continuous hyperthermic peritoneal perfusion (CHHP) and survived 23 months.
Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy.